Rare Disease Regional Lead - Northeast
Posted on: 9 Apr 2021
Cambridge, MA
Job Description
Job Description
In this highly visible position, you will be responsible for providing strategic and leadership direction for the Northeast region of account executives in support of the continued launch for a first of its kind therapy for the treatment of spinal muscular atrophy. The person in this role will be responsible for developing regional business plans. They will recruit, train, develop, and mentor account executives to drive performance and foster a culture of empowerment and compliance to assure appropriate use of marketing and sales resources/materials in support of the therapys commercialization.
Responsibilities:
* Understands market drivers, Biogen, clients, and is able to evaluate growth opportunities and develop a strategy that aligns with organizational priorities and available resources.
* Effectively delegates and manages all resources and budgets for their region.
* Attracts, develops, and retains high performing internal/external talent to effectively meet business expectations.
* Drives a culture of collaboration, shared accountability, innovation, creativity, and crisp, high-quality decision-making.
* Provides personalized coaching and situational leadership practices to develop individual/team skills and abilities to meet performance expectations.
* Builds effective relationships with marketing to execute marketing programs that drive growth and brand development (e.g. building an integrated marketing/sales strategy grounded in competitor information and consumer insights).
* Effectively communicates to marketing regional goals so that they can develop tools/programs that enable them to deliver performance expectations. Ensures their account executives are using marketing tools appropriately.
* Identifies patients through market development and physician education.
* Builds and effectively executes on a strategic regional plan on how to approach key accounts and institutes.
* Can identify/build/maintain relationships to grow their region and to maximize sales.
Qualifications
Qualifications:
* 7+ years of sales experience in the hospital/academic medical center (biotech/rare disease experience is an advantage)
* 3+ years of managing, motivating and inspiring field-based teams.
* Must be familiar with relevant legal and regulatory environment and capable of managing others to operate compliantly.
* Can identify issues quickly and can develop recommendations to resolve.
* Establishes effective relationships through mutual respect and trust in dealing with others.
* Ability to work in close collaboration with multiple functions including sales, marketing, advocacy, and HR.
* Must be comfortable spending ~60% of time traveling; overnight travel required.
Education:
Bachelors degree required. Advanced or graduate degree is preferred.
Additional Information
This position will be responsible for providing strategic and leadership direction for the Northeast Region of account executives in support of the continued launch for a first of its kind therapy for the treatment of spinal muscular atrophy.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
